[1] KALANTAR-ZADEH K,JAFAR T H,NITSCH D,et al.Chronic kidney disease [J].Lancet,2021,398(10302):786-802.
[2] ABDALLAH M,NAGARAJAN S,MARTIN M,et al.Enhancement of podocyte attachment on polyacrylamide hydrogels with gelatin-based polymers[J].ACS Appl Bio Mater,2020,3(11):7531-7539.
[3] THEOCHARIS A,SKANDALIS S,GIALELI C,et al.Extracellular matrix structure [J].Adv Drug Deliv Rev,2016,97:4-27.
[4] BLOOM A B,ZAMAN M H.Influence of the microenvironment on cell fate determination and migration[J].Physiol Genomics,2014,46(9):309-314.
[5] THEOCHARIS A D,MANOU D,KARAMANOS N K.The extracellular matrix as a multitasking player in disease[J].FEBS J,2019,286(15):2830-2869.
[6] KECHAGIA J Z,IVASKA J,ROCA-CUSACHS P.Integrins as biomechanical sensors of the microenvironment[J].Nat Rev Mol Cell Biol,2019,20(8):457-473.
[7] SHEN D,PODOLNIKOVA N P,YAKUBENKO V P,et al.Pleiotrophin,a multifunctional cytokine and growth factor,induces leukocyte responses through the integrin Mac-1[J].J Biol Chem,2017,292(46):18848-18861.
[8] PIPERIGKOU Z,MANOU D,KARAMANOU K,et al.Strategies to target matrix metalloproteinases as therapeutic approach in cancer[J].Methods Mol Biol,2018,1731:325-348.
[9] LAW R,ABU-SSAYDEH D,WHISSTOCK J C.New insights into the structure and function of the plasminogen/plasmin system[J].Curr Opin Struct Biol,2013,23(6):836-841.
[10] BULOW R D,BOOR P.Extracellular matrix in kidney fibrosis:more than just a Scaffold[J].J Histochem Cytochem,2019,67(9):643-661.
[11] ULLAH I,ABU-DAWUD R,BUSCH J F,et al.VEGF-supplemented extracellular matrix is sufficient to induce endothelial differentiation of human iPSC[J].Biomaterials,2019,216:119283.
[12] ZHAO J H.Mesangial cells and renal fibrosis[J].Adv Exp Med Biol,2019,1165:165-194.
[13] BARTLETT C S,SCOTT R P,CAROTA I A,et al.Glomerular mesangial cell recruitment and function require the co-receptor neuropilin-1[J].Am J Physiol Renal Physiol,2017,313(6):F1232-F1242.
[14] ZHOU D,FU H,HAN Y,et al.Sonic hedgehog connects podocyte injury to mesangial activation and glomerulosclerosis[J].JCI Insight,2019,4(22):e130515.
[15] CHEN C A,CHANG J M,CHANG E E,et al.TGF-beta1 modulates podocyte migration by regulating the expression of integrin-beta1 and-beta3 through different signaling pathways[J].Biomed Pharmacother,2018,105:974-980.
[16] NGUYEN C,KONIG K,TAM F W K,et al.Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy[J].Clin Kidney J,2019,12(2):232-238.
[17] ZHANG J,MI Y,ZHOU R,et al.The TLR4-MyD88-NF-kappaB pathway is involved in sIgA-mediated IgA nephropathy[J].J Nephrol,2020,33(6):1251-1261.
[18] YANG F,CHEN J,HUANG X R,et al.Regulatory role and mechanisms of myeloid TLR4 in anti-GBM glomerulonephritis[J].Cell Mol Life Sci,2021,78(19-20):6721-6734.
[19] HASEBE A,TASHIMA H,IDE T,et al.Efficient production and characterization of recombinant human NELL1 protein in human embryonic kidney 293-F cells[J].Mol Biotechnol,2012,51(1):58-66.
[20] 杨蕊芳,刘昊凌.SGLT2抑制剂在糖尿病肾病中作用的研究进展[J].现代医学,2018,46(1):94-97.
[21] BUS P,PIERNEEF L,BOR R,et al.Apolipoprotein C-I plays a role in the pathogenesis of glomerulosclerosis[J].J Pathol,2017,241(5):589-599.
[22] JUIN S K,PUSHPAKUMAR S,SEN U.GYY4137 regulates extracellular matrix turnover in the diabetic kidney by modulating retinoid X receptor signaling[J].Biomolecules,2021,11(10):1477.
[23] NASTASE M V,ZENG-BROUWERS J,BECKMANN J,et al.Biglycan,a novel trigger of Th1 and Th17 cell recruitment into the kidney[J].Matrix Biol,2018,68-69:293-317.
[24] ZHANG Z,WU W,FANG X,et al.Sox9 promotes renal tubular epithelialmesenchymal transition and extracellular matrix aggregation via the PI3K/AKT signaling pathway[J].Mol Med Rep,2020,22(5):4017-4030.
[25] YUAN Q,TAN R J,LIU Y.Myofibroblast in kidney fibrosis:origin,activation,and regulation[J].Adv Exp Med Biol,2019,1165:253-283.
[26] LIANG H,ZHANG Z,YAN J,et al.The IL-4 receptor alpha has a critical role in bone marrow-derived fibroblast activation and renal fibrosis[J].Kidney Int,2017,92(6):1433-1443.
[27] GERARDUZZI C,DI BATTISTA J A.Myofibroblast repair mechanisms post-inflammatory response:a fibrotic perspective[J].Inflamm Res,2017,66(6):451-465.
[28] ZHU X,SHI D,CAO K,et al.Sphingosine kinase 2 cooperating with Fyn promotes kidney fibroblast activation and fibrosis via STAT3 and AKT[J].Biochim Biophys Acta Mol Basis Dis,2018,1864(11):3824-3836.
[29] NAST C C.Medication-induced interstitial nephritis in the 21st century[J].Adv Chronic Kidney Dis,2017,24(2):72-79.
[30] MOLEDINA D G,PERAZELLA M A.Drug-induced acute interstitial nephritis[J].Clin J Am Soc Nephrol,2017,12(12):2046-2049.
[31] XU J,SHEN X,WEI X,et al.Identification of blood-based key biomarker and immune infiltration in Immunoglobulin a nephropathy by comprehensive bioinformatics analysis and a cohort validation[J].J Transl Med,2022,20(1):145.
[32] TORRES-SALIDO M T,SANCHIS M,SOLE C,et al.Urinary neuropilin-1:a predictive biomarker for renal outcome in lupus nephritis[J].Int J Mol Sci,2019,20(18):4601.
[33] LI Y,LI W,JIANG H.Vitamin D and hydroxychloroquine reduce renal injury and Ki67 expression in a rat model of IgA nephropathy via TLR4[J].Chin Med J(Engl),2021,134(23):2896-2898.
[34] MCGARAUGHTY S,DAVIS-TABER R A,ZHU C Z,et al.Targeting anti-TGF-beta therapy to fibrotic kidneys with a dual specificity antibody approach[J].J Am Soc Nephrol,2017,28(12):3616-3626. |
